Using laboratory engineered tissue, scientists at the University of Colorado Anschutz Medical Campus have created a full thickness, biodegradable patch that holds the promise of correcting congenital heart defects in infants, limiting invasive surgeries and outlasting current patches.
Valneva wins FDA approval for the first chikungunya vaccine – Pharmaceutical Technology
Valneva has also applied for marketing approval for Ixchiq in Canada and Europe. Image Credit: frank600 / Getty Images. The US Food and Drug Administration
November 10, 2023